Helen Carlile

Current Organisation: THIRTYFIVEBIO LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£495,254

Aug 23 - Aug 24

Enabling translational studies and clinical entry plan in gastro-intestinal inflammatory diseases and cancers for human GPR35 antagonist lead molecules.

Innovate UK award to THIRTYFIVEBIO LIMITED and Helen Carlile

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}